BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16515331)

  • 1. [Specific immunotherapy with tablets].
    Krankenpfl J; 2005; 43(7-10):260. PubMed ID: 16515331
    [No Abstract]   [Full Text] [Related]  

  • 2. Epicutaneous allergen administration: a novel approach for allergen-specific immunotherapy?
    Werfel T
    J Allergy Clin Immunol; 2009 Nov; 124(5):1003-4. PubMed ID: 19895988
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous specific immunotherapy for seasonal allergic rhinitis: a review of treatment practices in the US and Europe.
    Cox L; Calderon MA
    Curr Med Res Opin; 2010 Dec; 26(12):2723-33. PubMed ID: 20979432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Instead of hyposensitization by injection. Dissolving immunotherapy under the tongue?].
    Klein F
    MMW Fortschr Med; 2007 Jan; 149(3):16. PubMed ID: 17632861
    [No Abstract]   [Full Text] [Related]  

  • 6. Polymerized allergens.
    Patterson R; Suszko IM
    Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1983; (78):241-6. PubMed ID: 6354090
    [No Abstract]   [Full Text] [Related]  

  • 7. Is oral immunotherapy too good to be true?
    Ledford DK
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):1-2. PubMed ID: 14756456
    [No Abstract]   [Full Text] [Related]  

  • 8. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
    Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
    J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoid sublingual immunotherapy.
    Palma-Carlos AG; Santos AS; Branco-Ferreira M; Pregal AL; Palma-Carlos ML
    Eur Ann Allergy Clin Immunol; 2006 Mar; 38(3):87-9. PubMed ID: 16752693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
    Panzner P; Petrás M; Sýkora T; Lesná I
    Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in specific immunotherapy for allergic rhinitis.
    Bousquet J; Hejjaoui A; Michel FB
    Clin Exp Allergy; 1991 Jan; 21 Suppl 1():259-61. PubMed ID: 2032157
    [No Abstract]   [Full Text] [Related]  

  • 12. [Allergic rhinitis. This year the pollen count is expected to be high].
    Hellmann A
    MMW Fortschr Med; 2006 May; 148(21):51-2. PubMed ID: 16796189
    [No Abstract]   [Full Text] [Related]  

  • 13. [Specific brief immunotherapy receives MMW Drug Prize 2004. Four pricks expel pollen allergy].
    Füessl HS
    MMW Fortschr Med; 2004 Sep; 146(37):13. PubMed ID: 15887695
    [No Abstract]   [Full Text] [Related]  

  • 14. Sublingual immunotherapy.
    Corrigan C
    J Allergy Clin Immunol; 2007 Feb; 119(2):515; author reply 515-7. PubMed ID: 17187850
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and tolerability of high dose sublingual immunotherapy in patients with rhinoconjunctivitis.
    Worm M
    Eur Ann Allergy Clin Immunol; 2006 Dec; 38(10):355-60. PubMed ID: 17274520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary experimental and clinical results with inactivated allergens conjugated to the Corynebacterium granulosum-derived immunomodulator P40.
    Henocq E; Prouvost-Danon A; Bizzini B
    Boll Ist Sieroter Milan; 1987; 66(1):70-7. PubMed ID: 3620123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cluster immunotherapy with a glutaraldehyde-modified mixture of grasses results in an improvement in specific nasal provocation tests in less than 2.5 months of treatment.
    Subiza J; Feliú A; Subiza JL; Uhlig J; Fernández-Caldas E
    Clin Exp Allergy; 2008 Jun; 38(6):987-94. PubMed ID: 18445082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A clinical evaluation of methods fpr specific hyposensitization in pollinosis].
    Bulakhova EK
    Vrach Delo; 1991 Mar; (3):63-5. PubMed ID: 2042353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiallergen immunotherapy for allergic rhinitis and asthma.
    Nelson HS
    J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grass pollen hyposensitization versus placebo therapy.
    Weyer A; Heritier CL; David B
    Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1983; (78):101-7. PubMed ID: 6354089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.